Compass Therapeutics Inc. (CMPX) — Financial Flexibility Index
Compass Therapeutics Inc. (CMPX) has a Financial Flexibility Index of -0.92x as of March 2026. Free cash flow of $-17.19 Million (operating CF $-17.27 Million minus capex $82.00K) represents -1% of total liabilities ($18.70 Million). Check strategic asset allocation of Compass Therapeutics Inc. to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Compass Therapeutics Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Compass Therapeutics Inc. across 8 annual periods. See CMPX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Compass Therapeutics Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for Compass Therapeutics Inc.. For the full company profile including market capitalisation, see market cap of Compass Therapeutics Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.15x | $-49.12 Million | $-49.14 Million | $22.80 Million | ▲ +27.1% |
| 2024 | -2.95x | $-44.81 Million | $-44.85 Million | $15.17 Million | ▲ +39.3% |
| 2023 | -4.87x | $-40.59 Million | $-40.62 Million | $8.34 Million | ▼ -158.5% |
| 2022 | -1.88x | $-33.91 Million | $-34.12 Million | $18.01 Million | ▼ -42.3% |
| 2021 | -1.32x | $-18.10 Million | $-19.67 Million | $13.68 Million | ▲ +40.7% |
| 2020 | -2.23x | $-26.70 Million | $-26.80 Million | $11.97 Million | ▼ -962.8% |
| 2019 | -0.21x | $-31.27 Million | $-31.74 Million | $148.98 Million | ▲ +0.9% |
| 2018 | -0.21x | $-31.66 Million | $-33.68 Million | $149.40 Million | — |